Today, lawmakers voted to reauthorize Medicaid expansion in New Hampshire, ensuring thousands of Granite Staters have access to the affordable healthcare they need. The vote is particularly poignant for the dozens of cancer patients and survivors who lobbied for passage of this legislation as June marks Cancer Survivors Month.
Today, the American Cancer Society Cancer Action Network submitted public comment opposing Arkansas Gov. Sarah Huckabee Sanders’s proposed changes to ARHOME, which would require over 300,000 Arkansans to report work and community activities to the state to remain eligible for their current Medicaid coverage.
Today, the American Cancer Society Cancer Action Network submitted public comment opposing Arkansas Gov. Sarah Huckabee Sanders’s proposed changes to ARHOME, which would require over 300,000 Arkansans to report work and community activities to the state to remain eligible for their current Medicaid coverage.
TOPEKA, Kan . – Last week, the Kansas State Legislature completed another session and left the critical issue of Medicaid expansion unresolved, despite bipartisan support from state voters to do so. State legislators are going on an 8-month break at the same time the state is restarting eligibility redeterminations for
Today, the U.S. House of Representatives, in a 217-215 vote, passed the Limit, Save, Grow Act, advancing provisions that would greatly restrict access to affordable care and risk progress in the fight against cancer.
Today, the American Cancer Society Cancer Action Network (ACS CAN) sent a letter to Speaker Kevin McCarthy and House Democratic Leader Hakeem Jeffries detailing concerns on provisions in the Limit, Save and Grow Act that would restrict access to affordable health care and risk progress in cancer research.
This morning, House Speaker Kevin McCarthy proposed concepts to address the debt limit that would jeopardize Americans’ access to meaningful, affordable health care by implementing work requirements for the Medicaid health insurance program and threaten federally-funded cancer research by shrinking discretionary spending.
